Ken Griffin Io Biotech, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Io Biotech, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 58,622 shares of IOBT stock, worth $68,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,622
Previous 51,867
13.02%
Holding current value
$68,587
Previous $97,000
4.12%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding IOBT
# of Institutions
18Shares Held
27MCall Options Held
988KPut Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$7.22 Million1.43% of portfolio
-
Novo Holdings Hellerup, G75.09MShares$5.95 Million0.71% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.64MShares$4.26 Million1.99% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$2.74 Million0.2% of portfolio
-
Morgan Stanley New York, NY2.2MShares$2.57 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $33.7M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...